stocktools
Offerings // Scinai Immunotherapeutics Ltd.

SCNI offering history

Every offering-related filing in Scinai Immunotherapeutics Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 482 filings back to Nov 13, 2014.

Last executed offering
Sep 19, 2023
424B5 — priced deal (shares or notes)
Last registration (announced)
May 8, 2026
F-3 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
2
S-1/S-3/F-series registrations
DateFilingWhat it means
May 19, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 19, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 8, 2026F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Oct 6, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 30, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 22, 2025F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Sep 8, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 5, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 15, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 13, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 12, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 11, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Mar 4, 2025F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
May 16, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 13, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 30, 2024F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Jan 2, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 2, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 2, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 26, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 22, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 30, 2023F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Sep 19, 2023424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 7, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 28, 2023424B2 →EXECUTEDProspectus supplement priced — shares or notes (large filers: often a bond deal)
Aug 25, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 18, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Dec 20, 2022424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Dec 15, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 14, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Dec 12, 2022F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 16, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 29, 2022F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Dec 28, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 27, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 1, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 29, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 2, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 10, 2020EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 29, 2020F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
SCNI offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full SCNI workspace →
SCNI offering FAQ

When did SCNI last execute an offering?

Per SEC filings, Scinai Immunotherapeutics Ltd.'s most recent priced offering document is a 424B5 filed 2023-09-19. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did SCNI last announce or register an offering?

The most recent registration is a F-3 filed 2026-05-08. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.